Medical Marijuana and Hemp News
Medical Marijuana and Hemp News
DOJ Rescheduling Order: Analyzing 280E Tax Implications for Medical Cannabis Businesses
The U.S. Department of Justice's April 2026 medical cannabis rescheduling order offers potential 280E tax relief for qualifying operators. Understand the…
GCNC and Whitney Economics Report Details Europe’s Expanding Role in Global Medical Cannabis Market
A new GCNC and Whitney Economics report details the expansion of the European medical cannabis market, examining regulatory evolution, international trade…
Sourcing Challenges for Ibogaine May Slow US Veterans’ Psychedelic Therapy Push
The US Department of Veterans Affairs is advancing psychedelic therapy for veterans, but sourcing ibogaine for research presents a significant hurdle. Lea…
New Telehealth Platform Aims to Streamline Prescription CBD Access in the US
A new telehealth platform in the US aims to provide a regulated clinical pathway for prescription CBD access, offering clinician-led consultations and pha…
Modern Canna Expands Cannabis Quality Solutions with Strategic Investment in CannaGuard PRO
Modern Canna expands its suite of cannabis quality solutions with a strategic investment in CannaGuard PRO, integrating EPA-registered sanitation for comm…
Vireo Growth Inc. Announces Intent to Acquire Bridgewell Agribusiness for Estimated US$10.26 Million
Vireo Growth Inc. announced its intent to acquire Bridgewell Agribusiness LLC for an estimated US$10.26 million, expanding its footprint in the organic an…
Congressional Inaction Expected on US Hemp THC Product Ban, Industry Faces Significant Restructuring
The US hemp industry faces a significant challenge as Congress is unlikely to prevent a new federal hemp THC product ban from taking effect in November, a…
Curaleaf Announces 1-for-3 Reverse Stock Split in Preparation for U.S. Exchange Uplisting Amid Rescheduling Developments
Curaleaf Holdings Inc. (CURA) announced a 1-for-3 reverse stock split, effective June 5, 2026, to meet U.S. exchange criteria for uplisting. This move ant…
Federal Medical Cannabis Rescheduling Prompts State-Level Policy Reassessment and Market Shifts
Explore how federal medical cannabis rescheduling to Schedule III is influencing state-level policy, potentially expanding access, and reshaping market dy…
New Study Suggests Cannabinoids May Offer Relief for Chronic Pain Conditions Including Fibromyalgia and Arthritis
New research indicates medical cannabis, including both THC and non-intoxicating cannabinoids, may significantly improve chronic pain symptoms for patient…
